Three years after introducing Hemgenix, the first gene therapy for hemophilia B, CSL Behring has released long-term data ...

Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...

It took several attempts and much debate, but on Friday, the Centers for Disease Control and Prevention's (CDC’s) newly ...

Interestingly, despite the autumn’s upward trend, November’s haul is the first in 2025 that doesn’t outweigh the ...

Uncertainty reigned early this year with the inauguration of President Donald Trump and his threats to impose tariffs and ...

With FDA approval to treat marginal zone lymphoma (MZL), Bristol Myers Squibb’s Breyanzi has become the first CAR-T therapy ...

Avalere Health has hired Sarah Hall as president of U.S. marketing, tapping the direct-to-consumer expert to lead its team ...

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to ...

In the U.S., receiving healthcare depends on information changing hands. And that’s not just for patients undergoing ...

The Centers for Disease Control and Prevention's (CDC’s) newly reworked Advisory Committee on Immunization Practices (ACIP) ...

A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). | A trio of ...